Industries
Showing 251–260 of 273 results
-
Non-small-cell Lung Carcinoma (NSCLC) Market in China
At 3% CAGR, the non-small-cell lung carcinoma (NSCLC) market in China is projected to reach 967 thousand units by 2027, according to data and analytics company StrategyHelix.
-
Nasopharyngeal Cancer Market in China
According to a statistic by StrategyHelix, the nasopharyngeal cancer market in China, in terms of volume, is expected to expand at a CAGR of 1.2% in the next five years.
-
Head and Neck Cancer Market in China
The head and neck cancer market in China, in terms of volume, is expected to expand at a CAGR of 1.7% from 2021 through 2027, according to data and analytics company StrategyHelix.
-
Oncology Drug Market in China
The oncology drug market in China is poised to grow at a CAGR of around 13.3% over the analysis period of 2021 to 2027, according to data and analytics company StrategyHelix.
-
Content-Commercial Solution Market in China
The content-commercial solution market in China is anticipated to expand positively at a CAGR of 31.7% during the forecast period (2021-2027), according to data and analytics company StrategyHelix.
-
Paid Membership Market in China
A statistic by StrategyHelix indicates that the paid membership market in China is anticipated to expand positively at a CAGR of 15.5% during the forecast period (2021-2027).
-
Online Advertising Market in China
According to a statistic by StrategyHelix, the online advertising market in China is anticipated to expand positively at a CAGR of 15.9% during the forecast period (2021-2027).
-
Online Content Community Market in China
The online content community market in China is expected to increase at a CAGR of 21.8% till 2027, according to data and analytics company StrategyHelix.
-
Online Content Market in China
According to StrategyHelix, the online content market in China is expected to increase by US$ 431 billion during 2021-2027, expanding at a CAGR of 17.1% during the forecast period.
-
Biochip Market in China
According to a statistic by StrategyHelix, the biochip market in China is set to increase by US$ 2,346 million during 2021-2027, growing at a CAGR of 23.2% during the forecast period.